The cytotoxic effect of combined hyperthermia and taxane chemotherapy on ovarian cancer cells: results of an in vitro study

Eur Surg Res. 2012;48(2):55-63. doi: 10.1159/000333393. Epub 2011 Dec 23.

Abstract

Purpose: Hyperthermic intraperitoneal chemotherapy (HIPEC) is under continuous evaluation as a potential treatment for ovarian cancer. The purpose of this study was to evaluate the effect of chemotherapy, drug concentration and temperature.

Materials and methods: We examined the combined effects of hyperthermia and taxane chemotherapy on the clonogenic survival of the human ovarian carcinoma SHIN-3 cell line in vitro.

Results: When hyperthermia was combined with chemotherapy, the median lethal dose (LD50) was equivalent regardless of the duration of exposure, and was independent of the exposure temperature. Taxanes showed a similar LD50 over the temperature range tested.

Conclusions: In our study, hyperthermia does not increase the cytotoxic effects of taxanes, at least for the concentrations and durations tested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cell Line, Tumor / drug effects
  • Cold Temperature*
  • Combined Modality Therapy
  • Cystadenocarcinoma, Serous / pathology*
  • Docetaxel
  • Female
  • Humans
  • Lethal Dose 50
  • Middle Aged
  • Ovarian Neoplasms / pathology*
  • Paclitaxel / pharmacology*
  • Taxoids / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Paclitaxel